- Have any questions?
- [email protected]
Revolutionize Discovery with Human3D Disease Models
Generate more human-like responses with more human-like tissues using VivoSphere™ tissue engineering solutions.
0
+
Years Experienced
0
+
Vivosphere model developed
0
peer reviewed articles published
About VivoSphere
VivoSphere™ is pioneering advancements in drug discovery and toxicity testing through cutting-edge tissue engineering technologies. Specializing in human 3D disease models, we create physiologically relevant environments that enhance the accuracy and predictability of in vitro studies.
Our expertise spans 3D cell culture, oncology research, and high-throughput screening, offering innovative solutions that replicate complex tissue microenvironments. By integrating high cell density encapsulation and assay-ready 3D tissues, we provide researchers with more reliable and translatable data for drug development.
With a commitment to scientific excellence and innovation, we strive to improve preclinical testing processes, accelerating the development of safer and more effective therapeutics.
VivoSphere™ provides 3D cell culture models for in vitro drug discovery and toxicity testing using tissue engineering technologies.
3D Cell Culture
More physiologically relevant condition for cell culture.
Oncology
Replicate 3D tumor microenvironment with control over extracellular matrix components and mechanical properties.
HTS screening
Assay-ready 3D tissues compatible with lab automation system.
VivoSphere™ provides 3D cell culture models for in vitro drug discovery and toxicity testing using tissue engineering technologies.
3D Cell Culture
More physiologically relevant condition for cell culture.
Oncology
Replicate 3D tumor microenvironment with control over extracellular matrix components and mechanical properties.
HTS screening
Assay-ready 3D tissues compatible with lab automation system.
Key Features of VivoSphere™ Tissue-Engineered Models
Encapsulate key features of human biology in our 3D models to provide more translatable results for drug discovery.
- High inter- and intra-batch uniformity
- Customizable tissue microenvironments using hydrogels
- Support for a wide range of cell types, including non-aggregating cells
- High cell density encapsulation for improved assay readouts
- Ready-to-use formats suitable for high-throughput screening
These offerings are designed to provide more translatable results, thereby improving the predictability and efficiency of preclinical testing in drug development.
Testimonials
What our client say
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Events
- VivoSphere team nominated for the 2024 SLAS Ignite Award.
- VivoSphere was selected as the SLAS2024 Innovation AveNEW company. Meet us at SLAS2024 International Conference & Exhibition, Feb 3-7, Boston, MA.
- VivoSphere team won 2023 Alabama Launchpad Concept Stage.
- Our team attended and presented our work at 2023 AACR conference in Orlando, FL.
Company News
- VivoSphere selected as recipient of $100k Innovate Alabama Supplemental Grant
- VivoSphere Secures $350K NIH Award: Pioneering High-Throughput Screening with 3D Tissue-Engineered Models
- Dr. Elizabeth Lipke, co-founder of VivoSphere, inducted into the American Institue for Medical and Biological Engineering (AIMBE) College of Fellows.
- VivoSphere featured in a feature article by Auburn University New Venture Accelerator.
- Winner of 2023 Alabama Launchpad Concept Stage.
- Finalist of 2023 Alabama Launchpad.
- Startup Showcase at 2023 Gener8tor Healthcare Conference.
- 2022 BioAlabama Annual Conference.
- Awardee of the 2021 NSF I-Corps Grant for customer discovery.
- Winner of 2019 LAUNCH Innovation Grant from Auburn University.
Article
- Rapid Production of Cell‐Laden Microspheres Using a Flexible Microfluidic Encapsulation Platform
- Droplet Microfluidics-Based Fabrication of Monodisperse Poly (ethylene glycol)-Fibrinogen Breast Cancer Microspheres for Automated Drug Screening Applications
- Engineered cardiac tissue microsphere production through direct differentiation of hydrogel-encapsulated human pluripotent stem cells
- Encapsulation of Equine Endothelial Colony Forming Cells in Highly Uniform, Injectable Hydrogel Microspheres for Local Cell Delivery
- Microfluidic Production of Cell-Laden Microspheroidal Hydrogels with Different Geometric Shapes
- Cell engraftment, vascularization, and inflammation after treatment of equine distal limb wounds with endothelial colony forming cells encapsulated within hydrogel microspheres
VivoSphere in the news
Auburn Engineering faculty start-up VivoSphere™ nominated for prestigious Ignite Award
New Innovative Approaches to Lab Automation
VivoSphere™ develops advanced 3D tissue-engineered models for drug discovery and toxicity testing, enhancing preclinical research accuracy and accelerating safer, more effective therapeutic development.
Quick Links
Quick Links
Contact Info
VivoSphere™ develops advanced 3D tissue-engineered models for drug discovery and toxicity testing, enhancing preclinical research accuracy and accelerating safer, more effective therapeutic development.
Quick Links
Quick Links